Caplight Directory>Companies>PolyActiva-preview>Polyactiva


PolyActiva

PolyActiva

Private
MelbourneHealthcare & Life Scienceshttps://polyactiva.com/

Last Round

Series C

May 30, 2025

Total Funding Raised

$25M

Company Overview

PolyActiva is a clinical-stage biopharmaceutical company developing a biodegradable, sustained-release drug delivery platform for ophthalmic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

biodegradable implantocular implantsustained drug deliveryglaucoma treatmentdrug delivery platformophthalmologylatanoprost implantintraocular pressureIOPlong-acting drug deliverydrug-eluting implantclinical-stage biopharmaDiabetic Macular EdemaDMEpatient adherencedrug-polymer conjugatemedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PolyActiva Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PolyActiva Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMay 30, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Wes Brazell

Chief Financial Officer

Executive Team

PolyActiva Investors

Notable investors and investment history

InvestorRounds
National Reconstruction Fund CorporationSeries C
Brandon CapitalSeries C
View all Investors

PolyActiva Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PolyActiva Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PolyActiva's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range32
Year Founded2010
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.